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In L6 myotubes, redistribution of a hemagglutinin (HA)
epitope-tagged GLUT4 (HA-GLUT4) to the cell surface oc-
curs rapidly in response to insulin stimulation and AMP-ac-
tivated protein kinase (AMPK) activation.We have examined
whether these separate signaling pathways have a convergent
mechanism that leads to GLUT4 mobilization and to changes
in GLUT4 recycling. HA antibody uptake on GLUT4 in the
basal steady state reached a final equilibrium level that was
only 81% of the insulin-stimulated level. AMPK activators
(5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)
and A-769662) led to a similar level of antibody uptake to that
found in insulin-stimulated cells. However, the combined
responses to insulin stimulation and AMPK activation led to an
antibody uptake level of20% above the insulin level. Increases
in antibody uptake due to insulin, but not AICAR or A-769662,
treatment were reduced by both wortmannin andAkt inhibitor.
The GLUT4 internalization rate constant in the basal steady
state was very rapid (0.43 min1) and was decreased during the
steady-state responses to insulin (0.18 min1), AICAR (0.16
min1), and A-769662 (0.24 min1). This study has revealed a
nonconvergentmobilizationofGLUT4 in response to activation
of Akt andAMPK signaling. Furthermore, GLUT4 trafficking in
L6 muscle cells is very reliant on regulated endocytosis for con-
trol of cell surface GLUT4 levels.
Insulin stimulates glucose uptake intomuscle and fat cells by
triggering the translocation of the facilitative glucose trans-
porter GLUT4 from intracellular storage vesicles to the plasma
membrane. However, because GLUT4 continuously cycles
between these vesicles and the plasma membrane both in the
absence and presence of insulin, it is conceivable that insulin
increases cell surface levels of the transporter by either increas-
ing the exocytic rate and/or decreasing the endocytic rate
and/or increasing the size of the recyclingGLUT4pool. GLUT4
trafficking has been extensively studied in adipocytes where it
has been found that the major effect of insulin is to stimulate
exocytosis (1–5), although it has been reported that insulin also
inhibits GLUT4 endocytosis (2, 6). A recent kinetic study using
a GLUT4 photolabel has revealed that exocytosis is a major site
of insulin regulation of GLUT4 traffic in both rat and human
skeletal muscle, but further studies on additional trafficking
kinetic parameters were limited by difficulties involved in
working with skeletal muscle strips (7). Similar conclusions
have been reached in studies on cardiac muscle cells (8). Klip
and co-workers (9) have carried out kinetic studies of GLUT4
trafficking in the L6 muscle cell line and have reported that
insulin increases cell surface GLUT4 by stimulating GLUT4
exocytosis. However, the basal rate ofGLUT4 recycling ismuch
faster in L6 cells than in adipocytes (4–6, 9) implicating a
potential role for endocytosis in regulating cell surface levels
of the transporter in these cells. Consistent with this possi-
bility, it has recently been shown in L6 cells that themitochon-
drial uncoupler 2,4-dinitrophenol, like insulin, also stimulates
GLUT4 translocation and does so by inhibiting GLUT4 endo-
cytosis (10). This is of interest because 2,4-dinitrophenol may
mimic the effects of exercise/contraction, which also stimulates
GLUT4 translocation in muscle. In contrast to insulin, which
regulates GLUT4 trafficking principally via the phosphatidyl-
inositol 3-kinase/Akt pathway, other agonists such as exercise
or mitochondrial poisons appear to do so, at least in part, via
activation of the stress kinase AMPK2 (11–13). Direct activa-
tion of AMPK using the AMPK activator AICAR enhances glu-
cose uptake intomuscle by increasing cell surfaceGLUT4 levels
(14–16). Despite this, there is relatively little data on the effects
of AMPK activation on GLUT4 trafficking in muscle, although
it has been reported that AMPKmay regulate GLUT4 endocy-
tosis (7, 8).Many of these studies into AMPK-mediated glucose
uptake have relied on AICAR, which has been reported to acti-
vate pathways other than AMPK (reviewed in Ref. 17).
In this study, we have extensively characterized GLUT4 traf-
ficking kinetics in L6 myotubes stimulated with a range of ago-
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nists, including insulin and a more direct AMPK activator
recently described in the literature, A-769662 (17, 18). We
report thatAMPKagonists and insulin added simultaneously to
L6myotubes resulted in additive effects onGLUT4 levels at the
cell surface and in the recycling pathway, indicating the pres-
ence of distinct pools of GLUT4 in muscle cells. Furthermore,
our studies indicate a hitherto unrecognized role for endocyto-
sis in the trafficking of GLUT4 in response to a range of stimuli
in muscle cells.
EXPERIMENTAL PROCEDURES
Cell Culture—L6myoblasts (up to passage 25) were cultured
in -minimal essential medium (Lonza) supplemented with
10% heat-inactivated fetal calf serum (Hyclone) and 1% antibi-
otic/antimycotic (Invitrogen) at 37 °C in 10% CO2. For differ-
entiation into myotubes, cells were cultured in -minimal
essential medium supplemented with 2% heat-inactivated fetal
calf serum at 37 °C in 10% CO2 and were maintained in this
medium post differentiation. Myotubes were used for experi-
ments 5–9days after the initiation of differentiation. To express
HA-GLUT4 in L6 cells, myoblasts were infected with retrovi-
rus, as described previously (5, 19), and differentiated as de-
scribed above.
Akt Phosphorylation—L6 myotubes cultured in 96-well
plates were incubated  inhibitor (100 nM wortmannin or 10
MAkti) for 15min prior to stimulationwith 200 nM insulin for
30 min. Cells were lysed in lysis buffer (2% SDS (Sigma) in PBS,
pH 7.4, protease inhibitor mixture (Roche Applied Science),
phosphatase inhibitor mixture (Roche Applied Science)) and
sonicated for 6 s before being centrifuged at 15,000  g for 20
min at 15 °C. The protein concentration of supernatant was
determined by BCA assay. 5-g samples of protein were
resolved by 10% SDS-PAGE and Western-blotted using Akt-2
antibody (Upstate) and anti-phospho-Akt (Ser473) antibody
(Cell Signaling). In each case, signals were detected by ECL
(Pierce) and quantified using an Optichem detector with asso-
ciated software (UltraViolet Products).
Transition State Assay—Measurement of cell surface HA-
GLUT4 as a percentage of total cellular HA-GLUT4 was per-
formed in 96-well plates as described previously. Briefly, cells
were serum-starved for 16 h in -minimal essential medium
(without bicarbonate) with 20 mM HEPES and 0.2% bovine
serumalbumin (Celliance) andmaintained in thismediumdur-
ing subsequent treatments. Cells were incubated with 100 nM
wortmannin (Calbiochem) or 10 M Akti (P. Shepherd, Auck-
land, New Zealand) where indicated for 15 min prior to insulin
stimulation. Myotubes were stimulated with 200 nM insulin, 2
mM AICAR, or 100 M A-769662 (K. Sakamoto, Dundee, Scot-
land, United Kingdom) for the times indicated in the figure
legends. To investigate additivity between insulin and AICAR,
both agonists were added simultaneously. Cells were subse-
quently fixed but not permeabilized, and the amount of
HA-GLUT4 present at the plasma membrane was determined
from the accessibility of the HA epitope to anti-HA antibody
(Covance). Finally, cells were incubated with 20 g/ml goat
anti-mouse Alexa 488-conjugated secondary antibody (Molec-
ular Probes, Invitrogen). After washing, fluorescence (emission
485 nm/excitation 520 nm) was measured in bottom reading
mode using a fluorescent microtiter plate reader (FLUOstar
Galaxy; BMG Labtechnologies). All values were expressed as a
percentage of total GLUT4 that was determined from anti-HA
antibody labeling of permeabilized cells.
Comparison of Recycling HA-GLUT4 with Total HA-GLUT4—
L6myotubes cultured in 96-well plates were serum-starved for
16 h, and then 200 nM insulin and/or 2mMAICARwas added to
cells 30 min before anti-HA antibody. To measure GLUT4
recycling with the cell surface, basal or stimulated myotubes
were labeled with saturating concentrations of protein-G affin-
ity column (Pierce) purified anti-HA antibody for 180min. The
saturating concentration of antibodywas experimentally deter-
mined as 50 g/ml. Wells being used to measure total cellular
GLUT4 were not labeled with antibody. Cells were moved to
4 °C, washed extensively with ice-cold PBS, and fixed with 3%
paraformaldehyde (Science Services). All cells were blocked
and permeabilized (0.1% saponin (Sigma), 3% goat serum
(Sigma), and 1% bovine serum albumin in PBS (12.5 mM
Na2HPO4, 154 mM NaCl, pH 7.2)). To determine total GLUT4
levels, unlabeled cells were labeled with anti-HA antibody for
60 min. Cells prelabeled with anti-HA antibody did not receive
additional antibody. Finally, cells were incubated with goat
anti-mouse Alexa 488-conjugated secondary antibody (20 g/
ml) overnight. After washing, fluorescence was determined as
described above. Antibody uptake was expressed as a percent-
age of total HA-GLUT4.
HA-GLUT4 Recycling; Anti-HA Antibody Uptake Assay—L6
myotubes cultured in 96-well plates were serum-starved for
16 h in-minimal essentialmedium (without bicarbonate)with
20 mM HEPES and 0.2% bovine serum albumin. For measure-
ment of steady-state trafficking of HA-GLUT4 under insulin
and AICAR- and A-769662-stimulated conditions, 200 nM
insulin and/or 2 mM AICAR or 100 M A-769662 was added to
cells 30 min before anti-HA antibody. For uptake experiments
in the presence of inhibitor, 100 nM wortmannin or 10 M Akti
was added 15 min prior to insulin stimulation. Basal or stimu-
lated myotubes were labeled with 50 g/ml anti-HA antibody
for the indicated times. Cells were moved to 4 °C, washed
extensively with ice-cold PBS, and fixed with 3% paraformalde-
hyde. Cells were blocked and permeabilized before being incu-
bated with goat anti-mouse Alexa 488-conjugated secondary
antibody (20 g/ml) overnight. Fluorescence was determined
as described above. All values were normalized to fluorescence
of insulin-stimulated samples that were incubated with anti-
body for 180 min.
Wide field epifluorescent images (40) of cells in 96-well
plates were automatically obtained on the ImageXpressTM
5000 inverted epifluorescent imaging system, software, and
robotics (Molecular Devices). Prior to imaging, nuclei were
labeled with Hoechst fluorescent dye (1:10,000 dilution)
(Invitrogen). Hoechst dye and Alexa 488 (Anti-HA antibody)
fluorophores were excited at 360 (20) and 480 (20) nm,
respectively, and detected with corresponding channels at 460
(25) and 535 (25) nm. For presentation, images were
exported to Photoshop 6.0 (Adobe).
HA-GLUT4 Internalization Assay—L6myotubes cultured in
96-well plates were stimulated for 30 min, and surface HA-
GLUT4 was pulse-labeled with anti-HA antibody (50g/ml) at
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4 °C for 45 min. Following extensive ice-cold washes to remove
unbound antibody, prewarmedmediumwas added to themyo-
tubes, and theywere immediately returned to 37 °C for the indi-
cated periods of time. Cells were subsequently moved back to
4 °C, washedwith ice-cold PBS, and fixed. Surface antibodywas
detected using goat anti-mouse Alexa 488-conjugated second-
ary antibody, and fluorescencewas detected as described above.
Data were normalized to give values as a percentage of the orig-
inal (0 min) cell surface signal.
Kinetic Analysis of Transition State Experiments—Overall
measures of the exocytosis and endocytosis rate constants for
GLUT4 to and from the plasma membrane were determined
for the system using a two-compartmental model outlined pre-
viously (20). The time constant and half-time for the transloca-
tion of GLUT4 was determined from transition state assays.
This assay measures the translocation of GLUT4 to the plasma
membrane following stimulation, the data from which was fit-
ted to Equation 1,
Lt  P0  P1e
t/  P1 (Eq. 1)
where L(t) is the amount of GLUT4 at the plasmamembrane at
time (t); P0 is the initial amount of GLUT4 at the plasma mem-
brane in the absence of the perturbing agent; P1 is the level of
GLUT4 at the plasma membrane after long insulin (or other)
treatment, and  is the time constant for the transition.
The half-time (t1⁄2) for the transition is given by t1⁄2   ln2.
However, this does not mean that the rate at which GLUT4
arrives at the plasma membrane is constant during this transi-
tion from the basal steady state to the stimulated steady state.
This could be due to differing amounts of GLUT4 available
for transport to the surface and/or varying exocytosis and endo-
cytosis rate constants for GLUT4, which only become constant
once the system is in steady state.
Kinetic Analysis of Steady-state Experiments—For the pur-
poses of this analysis only, the overall exocytosis and endocyto-
sis rate constants to and from the plasma membrane were
considered. These could be (and are highly likely to be) a com-
bination of several processes.
As in Refs. 5, 20, it was assumed that all unlabeled
HA-GLUT4 was immediately labeled upon insertion into the
plasma membrane. The increase in fluorescence as a function
of time is given by Equation 2,
Lt  P  Tekext T (Eq. 2)
whereL(t) is themeasured fluorescence as a function of time (t);
kex is the overall exocytosis rate constant of GLUT4 to the
plasma membrane; P is the amount of GLUT4 at the plasma
membrane, and T is the total amount of GLUT4 recycling from
internal structures to the plasma membrane.
The endocytosis rate constant, kin, can be inferred from these





To directly relate these parameters to the rate of GLUT4
trafficking, a combined parameter, R, defined as shown in
Equation 4 was determined,
R  k inP kex(T P) (Eq. 4)
which is a measure of the GLUT4 transport rate from the
plasmamembrane. As the system is in steady state, this is equiv-
alent to the total transport rate to the plasma membrane.
Kinetic Analysis of Internalization Assays—The internaliza-
tion of GLUT4 is controlled by the overall internalization rate
constant kin. However, once the labeled GLUT4 molecules are
internalized, they then become part of the pool, which can be
exocytosed at an overall rate kex.
The amount of antibody-labeled GLUT4 is equal to the
amount of GLUT4 present at the plasma membrane in the
steady state and is initially all localized at the cell surface. This is
distributed with time between the plasma membrane and the






kex kint (Eq. 5)
where L(t) is the measured fluorescence at the plasma mem-
brane and a function of time (t); P0 is the initial level at the
plasma membrane, and kin and kex are the overall exocytosis
and endocytosis rate constants of GLUT4 to and from the
plasma membrane, respectively.
Error Determination—The 95% confidence intervals for the
parameters were determined as part of the nonlinear regression
fitting to the data. These confidence intervals were used to
calculate the standard error for the parameters. The number of
standard errors spanning the interval was determined using
the Student’s t inverse cumulative distribution function. The
standard error is then the confidence interval divided by the
number of standard errors.
Significance—Given that the standard errors were deter-
mined from the confidence interval, it was not possible to per-
form normal tests of significance. Statistical significance was
tested by comparing the overlap of the confidence intervals of
the parameters. In the case of no overlap, the difference in the
values was statistically significant. An overlap of confidence
intervals, however, does not imply the converse but rather that
there may or may not be statistical significance. All the data
presented were analyzed for statistical significance, and only
those changes that were significant are discussed in the text.
RESULTS
In this study, we have used L6 cells as amodel system to study
GLUT4 trafficking. These cells have been extensively used by
Klip and co-workers (9, 10, 21, 22) to study the action of insulin
and other agonists on GLUT4 translocation in muscle. One of
the problems with these cells is that the differentiated L6 mus-
cle cells express very little GLUT4 presumably because the cells
are denervated (23). To overcome this problem, tagged GLUT4
reporters can be expressed to study GLUT4 trafficking. Al-
though many investigators use stably expressing cell clones
(10), this can be problematic due to the possibility for clonal
selection of an aberrant cell line as well as difficulties in main-
taining efficient muscle cell differentiation in stable clones. To
overcome these problems,we have developed a systemwhereby
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cells are infectedwith retrovirus-expressingHAepitope-tagged
GLUT4, which are then selected as pools rather than as clones.
The expression of GLUT4 in L6myotubes is uniform using this
system and at a level (3.5 mol/mg of protein) similar to endog-
enous GLUT4 in rat epitrochlearis muscle (calculated from
unpublished data from a previous study (7)).
Transition from the Basal to a Stimulated State—As shown
in Fig. 1C in the basal state, there is very little GLUT4 detected
on the plasma membrane in L6 myotubes similar to that
observed in adipocytes (5). Treatment with maximal concen-
trations of insulin or AICAR caused a significant increase in
surface levels of GLUT4. To more specifically study the role of
AMPK, we also used the specific agonist A-769662, which has
recently been reported to stimulate glucose uptake in L6 cells
(17). We selected doses of A-769662 and AICAR that achieved
a similar degree of AMPK activity as judged by the phosphory-
lation of acetyl-CoA carboxylase at serine 79 (data not shown).
This also resulted in a significant increase in plasmamembrane
levels of GLUT4.We thenmeasured the time course of GLUT4
translocation to the plasma membrane upon stimulation with
the different agonists (Fig. 1A). The amount of GLUT4 exposed
at the plasmamembrane was calculated as a percentage of total
cellular GLUT4 levels, which were measured by labeling per-
meabilized cells with anti-HA antibody (Fig. 1A). The increase
in cell surface GLUT4 in response to all the agonists was rapid
reaching a new steady state within 2–5min (Fig. 1A). Fits of the
data to Equation 1 determined that the transitions occurred
with short half-times of 1.21 and 1.27 min for insulin- and
AICAR-stimulated cells, respectively (Fig. 1B). A shorter half-
time (0.62min) was observed for A-769662-stimulated cells. At
10min, a new steady-state level ofGLUT4was reached, and this
was maintained for at least 60 min.
To determine whether the different agonists triggered
GLUT4 translocation via different mechanisms, we next exam-
ined the effects of combined treatments. The combined stimu-
lation with insulin and AICAR led to an increase in cell surface
GLUT4 to a level that was higher than with either stimulus
alone (Fig. 1C). All changes in the surface level of GLUT4 were
highly correlated with the total amount of GLUT4 present in
the recycling system revealed by measuring HA antibody
uptake over 3-h incubations. As observed in 3T3-L1 cells (5),
residual pools of GLUT4 remain intracellular even following
prolonged stimulation ofHAantibody uptake (Fig. 1D). In basal
cells, only 61% of the GLUT4 exchanges with the surface at
steady state. This value increased to 75 and 77% in insulin- and
AICAR-treated cells, respectively. Intriguingly, the amount of
GLUT4 in the recycling pathway in the presence of insulin plus
AICAR was significantly greater than that observed with either
stimulus alone (88%, p  0.001) indicating different mecha-
nisms of stimulation and the existence of different pools of
GLUT4. Also, these data indicate that a residual pool of intra-
cellular GLUT4, which does not recycle in the presence of a
range of agonists, is present in L6 cells.
Insulin caused a significant increase in Akt phosphorylation
in L6 cells. This effect was inhibited by the phosphatidylinositol
3-kinase inhibitor wortmannin and to a lesser extent by the Akt
inhibitor Akti (Fig. 2A). These data are similar to those previ-
ously reported for 3T3-L1 adipocytes (24). Correspondingly,
insulin-stimulated GLUT4 translocation to the plasma mem-
FIGURE 1. Transition to a steady-state GLUT4 distribution in L6 myo-
tubes. A, L6myotubes were stimulatedwith insulin (F), AICAR (f), A-769662
(Œ), and insulinAICAR (E) for the indicated times, and then cellswere fixed,
and the surface GLUT4 level was determined in fixed cells using an HA pri-
mary antibody and an Alexa 488 secondary antibody. Each data point repre-
sents the mean S.E. from three experiments. In some cases, the error bars
are smaller than the symbol. B, times for the half-maximal increase above
basal in cell surface HA-GLUT4were determined for insulin, AICAR, A-769662,
and the combination of insulin and AICAR. C, cell surface levels of GLUT4
reached at 30 min of incubation with the agonists were determined as a
percentage of the total cellular GLUT4 available in permeabilized cells.D, pla-
teau levels of antibody labeled-GLUT4 reached at 180min of incubationwith
the anti-HA antibody were determined as a percentage of the total cellular
GLUT4 available inpermeabilized cells. Results are themean S.E. from three
experiments.
FIGURE 2. Akt control of the transition from basal to insulin-stimulated
state. A, Akt activation was determined by blotting for phosphoserine 473 in
basal cells and cells treatedwith insulin (upper panels). Both basal and insulin-
treated cells were also treated with wortmannin (WM) and Akti as indicated.
Akt2 levels were determined from the same solubilized cell lysates (bottom
panels). B, rate of transition from the basal to the insulin-stimulated state in
the absence (F) and presence of wortmannin (f), and Akti (Œ) was deter-
mined in fixed cells using HA primary antibody and an Alexa 488 secondary
antibody. Each point represents the mean S.E. from three experiments. In
some cases error bars are smaller than the symbol.
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brane was reduced by50% in the presence of Akti and almost
completely abolished with wortmannin (Fig. 2B).
Steady-state GLUT4 Recycling—Once the transition phase is
over and a new steady state is reached, GLUT4 is distributed
between the plasma membrane and internal compartments,
and the rates of traffic into and out of the plasmamembrane are
equal. We have studied GLUT4 traffic at steady state by main-
taining L6 myotubes with anti-HA antibody throughout the
180-min incubations (Fig. 3, A and B). Over this time course,
the uptake of antibody is progressive, and labeled GLUT4 ap-
pears to reach similar intracellular locations under both basal
and insulin-stimulated conditions. Antibody-bound GLUT4 is
detected throughout the cell but is particularly evident in the
peri-nuclear region after long incubations with antibody (Fig.
3A). Note that the final levels of antibody bound to GLUT4 in
these incubations are reported relative to the maximum insu-
lin-stimulated level (Fig. 3B) but also correspond to those pre-
sented in Fig. 1D. The half-time of antibody uptake under all
conditions was 10–15 min, which is an order of magnitude
slower than the half-time for the transition from the basal to the
stimulated state (Fig. 1, A–C). Similar to the transition experi-
ments, the steady-state antibody uptake in response to insulin
and AICAR was additive and reached a higher level than either
stimulus alone (Fig. 3B).
We have approached the further analysis of the steady-state
antibody uptake by assuming that at steady state only a single
intracellular compartment contributes to the recycling. This is
an oversimplification. Furthermore, it is evident that the single
intracellular compartment from which GLUT4 is recruited is
not the same size for all stimulation conditions tested as there is
additivity in the responses to Akt and to AMPK stimulation.
Fitting the uptake assay data to Equation 2 allows calculation
of four parameters (Fig. 4). These are the initial plasma mem-
brane level P, the final plateau levelT, and the rate constants kex
and kin for movement out of and back into the single intracel-
lular compartment. The analysis of P and T values from the
steady-state equations confirm the additivity in the responses
to insulin and the AMPK agonists as observed in the transition
experiments (Fig. 4,A and B). These data suggest that the addi-
tivity in translocation of GLUT4 to the plasma membrane fol-
lowing stimulation with insulin and AMPK agonists (15–20%
increase in P) correlates closely with the additivity in the total
pool of recycling GLUT4 (15–20% increase in T).
The analysis of the rate constants for exo- and endocytosis
reveals that the rise in P strongly correlates with a reduction in
kin rather than to increased kex (Fig. 4D). The basal kin value was
extremely fast in L6 myotubes, and this was reduced by 50%
following treatment with insulin, AICAR, or A-769662. There
was a relatively small increase in kex response to insulin or insu-
lin combined with AMPK agonists (Fig. 4C). However, both
AICAR andA-769662 treatments alone led to a slight reduction
in kex. There was no additivity in response to combination
treatments with these AMPK agonists on either kex or kin.
FIGURE 3. HA antibody uptake reveals GLUT4 steady-state recycling
kinetics. L6 myotubes were maintained in the basal state or stimulated to a
steady state. Anti-HA antibody was then added, and the incubations with
antibody were continued for the indicated times. At the indicated times, the
bound antibody was determined by incubation with an Alexa 488 secondary
antibody. A, L6myotubes weremaintained in the basal state or stimulated to
steady state with insulin. At indicated times, L6 myotubes were visualized by
wide field epifluorescence microscopy at 40 magnification (scale bar, 20
m). B, L6 myotubes were maintained in the basal state () or stimulated to
steady state with insulin (F), AICAR (f), or insulin plus AICAR (E). Results are
themean S.E. from 3 to 7 experiments. In some cases error bars are smaller
than the symbol.
FIGURE 4. Kinetic parameters for GLUT4 recycling at steady state. The
uptake time courses for the increase in antibody bound to GLUT4 HA were
analyzed to give the following: A, plasma membrane level of HA-GLUT4, P;
B, total available GLUT4, T; C, kex rate constant; and D, kin rate constant. WM,
wortmannin. The analyzed data are from 3 to 7 experiments. Standard errors
calculated from the confidence intervals (see “Experimental Procedures”) for
the fits are shown.
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Wenext examined the effects of wortmannin andAkti on the
steady-state trafficking of GLUT4 (Fig. 5). Wortmannin com-
pletely inhibited the insulin-dependent increment in surface
levels of GLUT4 (P]). By contrast, and as evident in the transi-
tion experiments (Fig. 2B), Akti did not completely inhibit the
insulin effect on the initial cell surface levels. The wortmannin
and Akti effects on the total GLUT4 recycling pool (T) also
differed.Whereas wortmannin reducedT values obtained from
insulin-treated cells compared with those obtained from basal
cells, Akti reduced both basal and insulin-stimulated levels of
T, indicating that Akt is required for the insulin-stimulated
increase in the total GLUT4 recycling pool.
Both wortmannin and Akti markedly reduced steady-state
kex values in the presence and absence of insulin. The inhibitory
effect of Akti was less pronounced than the one observed with
wortmannin (Fig. 5C). Treatment with wortmannin and Akti
reduced basal kin values (Fig. 5D). However, the insulin-
dependent reduction in kin was partially retained in the pres-
ence of Akti, suggesting that the insulin-stimulated decrease in
GLUT4 internalization is independent of Akt.
To corroborate the steady-state kin values determined from
antibody uptake experiments, an alternative experimental pro-
tocol was used to determine the same parameter. Amore direct
method that quantified the rate of loss of cell surface tagged
GLUT4 was employed (Fig. 6A). This method confirmed a very
rapid loss of surface GLUT4 in the basal state. kin values deter-
mined by fitting the direct measurements of GLUT4 internal-
ization to Equation 5 closely matched those derived from the
steady-state antibody uptake (Fig. 6B) and confirmed a decrease
in kin in response to all three agonists.
The inhibitory effects of wortmannin and Akti on basal
GLUT4 trafficking complicate the analysis and interpretation
of whether these reagents have inhibitory effects on agonist-
stimulated trafficking. In an attempt to separate out the inhib-
itory effects on basal trafficking from those on stimulated traf-
ficking, all the steady-state parameters were calculated as a
fold-change over basal (Fig. 7A). The clearest effect of insulin
was to increase P by 2.9-fold. The effects on P were highly
correlatedwith insulin-associatedchanges inkin.The insulin-
dependent fold-change in kin was reversed by wortmannin
treatment but was only partially reversed by Akti treatment
(Fig. 7A).
We have also examined whether the amount of GLUT4 that
is moved to and from the cell surface becomes limiting during
responses to agonists. The transport rate (R) is a parameter that
reflects the dependence of GLUT4 traffic on the GLUT4 mass
that moves, as well as the time constant for movement. This
parameter was calculated from the kinetic parameters mea-
sured in the antibody uptake assay (Equation 4). Interestingly,
no major differences in GLUT4 traffic rates were apparent for
any of the conditions studied (Fig. 7B).
DISCUSSION
In this studywe have identified several novel aspects ofmem-
brane protein trafficking.We have found that GLUT4 recycling
is considerably faster in the muscle cell line L6 than in adipo-
cytes (1–5). Despite this, relatively low cell surface levels of
FIGURE 5. Inhibition of steady-state GLUT4 recycling bywortmannin and
Akti. Steady-state kinetic plots without inhibitor (Control) or following treat-
ment with wortmannin (WM) or the Akt inhibitor (Akti) were analyzed to give
the following:A, plasmamembrane level ofHA-GLUT4, P;B, the total available
GLUT4, T; C, kex rate constant; and D, kin rate constant. The analyzed data
are from three experiments. Standard errors calculated from the confi-
dence intervals (see “Experimental Procedures”) for the fits are shown.
FIGURE 6. Direct measurements of steady-state GLUT4 internalization.
A, L6 myotubes were maintained either in the basal steady state () or in a
steady state of stimulation with insulin (F), AICAR (f), or insulin plus AICAR
(E). Anti-HA antibody was bound to cell surface GLUT4 at 4 °C; excess anti-
body was removed by washing, and then the cells were incubated for the
indicated times at 37 °C. Surface-bound antibodywas then removed, and the
remaining antibody was detected with Alexa 488 secondary antibody.
Results are themean S.E. from 3 to 5 experiments. In some cases, error bars
are smaller than the symbols.B, internalization kin rate constants fromsteady-
state antibody uptake (dark bars) have been compared with the internaliza-
tion assay measurements (light bars). Standard errors calculated from the
confidence intervals (see “Experimental Procedures”) for the fits are shown.
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GLUT4 aremaintained in the basal state due to a very rapid rate
of endocytosis. In contrast to adipocytes, where the predomi-
nant effect of insulin action is on GLUT4 exocytosis, in L6 cells
insulin and AMPK agonists maintain enhanced plasma mem-
brane GLUT4 levels largely by inhibiting GLUT4 endocytosis.
This inhibition of endocytosiswas independent of theAkt path-
way. These data indicate that different cell types can coordinate
a similar transient change in cell surface GLUT4 by targeting
discrete limbs of the GLUT4 trafficking pathway. In addi-
tion, insulin stimulation and AMPK activation mobilize dis-
tinct pools of GLUT4 in L6 cells. Therefore, we suggest that
L6 cells may represent a novel system for dissecting the
mechanism of regulated GLUT4 endocytosis and studying
the mechanism by which distinct signaling pathways differ-
entially mobilize GLUT4.
Regulation of GLUT4 Endocytosis inMuscle—The trafficking
of GLUT4 in L6 cells differs from that in adipocytes in two
major respects. First, in the basal state the endocytosis rate
constant is 2–3-times faster than in 3T3-L1 adipocytes. This
suggests that different aspects of the GLUT4 trafficking itiner-
ary can be discretely regulated in different cell types resulting in
essentially the same outcome, which in this case is low expres-
sion of the transporter on the plasmamembrane in the absence
of insulin. The basal recycling rate ofGLUT4 is faster in L6 than
in 3T3-L1 adipocytes (5). If the basal endocytosis rate was sim-
ilar in both cell types, a greater proportion of GLUT4 would be
found at the plasma membrane in the basal state in L6 cells.
However, L6 cells seem to have adapted to this situation by
simply increasing the internalization of GLUT4. Thus, al-
though it is uncertain if this situation mimics GLUT4 traffick-
ing in skeletal muscle in vivo, particularly as we are using an
artificial overexpression system, these studies highlight the
enormous plasticity of the endosomal recycling system.
The second unique feature of GLUT4 trafficking in L6 cells is
that agonists, including insulin and AMPK activators, maintain
enhanced surface levels of GLUT4 in the steady state in large
part by inhibiting endocytosis. This mechanism, which also
exists in adipocytes (2, 4, 6), likely plays a greater role in L6 cells
due to the relative basal recycling kinetics. It will be of interest
to explore themechanism for regulated endocytosis of GLUT4.
GLUT4 internalization has been reported to occur by both
clathrin-mediated and clathrin-independent routes in both
3T3-L1 adipocytes and L6 myoblasts (6, 10). It is unlikely that
different agonists regulateGLUT4 endocytosis via independent
mechanisms because we failed to observe additivity between
different agonists. So far, an insulin-regulated signaling path-
way that specifically targets GLUT4 endocytosis has not been
reported. It does not appear to involve theAkt pathway because
Akti did not overcome this inhibitory effect, consistent with
previous studies in adipocytes (24). However, the effect was
blocked by wortmannin. An alternative possibility is that slow-
ing of endocytosis in response to insulin or other agonists may
be a mass action, nonsignal-mediated phenomenon. This is
supported by the steady-state transport rates (R, Fig. 7B), which
were approximately the same in all conditions studied. In this
model, the endocytosis rate may be operating close to its max-
imum capacity in the basal state. The increased delivery of
GLUT4 to the plasma membrane that occurs in response to
insulin and the other agonists may saturate this step causing
accumulation of GLUT4 at this site. As such, the rate (as
opposed to rate constant) of GLUT4 transport from the plasma
membrane remains the same in basal and stimulated cells.
The reduction in GLUT4 endocytosis with insulin contrasts
with previous studies (9, 10) where no insulin effect on GLUT4
internalizationwas reported in L6myoblasts. Althoughwe can-
not be certain of the nature of this discrepancy, one major dif-
ference is that in the previous study a 37 °C wash step was used
between incubation with the GLUT4 labeling antibody at 4 °C
and commencement of the internalization assay. In our study,
we initiated internalization by immediate substitution of the
cold antibody-labeling buffer with prewarmed buffer followed
by continuous incubation at 37 °C. In view of the greater differ-
ence in the initial data points in the internalization experiment
in these cells, omitting just 1–2min of the initial internalization
experiment, as is likely the case in the previous study (10), may
bias the fitting of the data and reduce the difference in the rate
constants obtained. We were also able to verify our findings of
an inhibitory effect with both insulin and AMPK agonists using
two different methods for measuring endocytosis adding fur-
ther support to our data. In both cases we observed a similar
degree of inhibition of GLUT4 endocytosis with insulin and
AICAR.
Mobilization of GLUT4 Intracellular Pools in Muscle—We
have previously suggested that there are at least two ways in
FIGURE 7. Rates and rate constants for GLUT4 steady-state internaliza-
tion. A, to isolate effects associated with inhibitor action on kinetic parame-
ters in the stimulated states, the fold-changes over basal levels were deter-
mined. B, steady-state transport rates, R	 kinP. All calculations in A and B are
meanvalues andS.E. from3 to7experiments. Standarderrors calculated from
the confidence intervals (see “Experimental Procedures”) for the fits are
shown.
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which the delivery of GLUT4 to the plasma membrane may be
increased as follows: either by increasing the rate of exocytosis
and/or by increasing the amount of GLUT4 located in the recy-
cling system. In adipocytes, both of these parameters are regu-
lated by insulin (5, 25), whereas in L6 cells insulin has little
effect on the exocytic rate as analyzed with a two-compartmen-
talmodel. It should be noted that an insulin effect selectively on
the exocytic specialized pool of GLUT4might bemasked by the
high basal recycling. Regardless we clearly observed an increase
in the total recycling pool of GLUT4 in response to both insulin
and AMPK agonists. Partial or incomplete mobilization of
GLUT4 has been reported in 3T3-L1 cells (5). Similarly in L6
cells, incubated under basal conditions, the entire cellular pool
of GLUT4 does not reach the cell surface even over time
courses extending to several hours. The size of the basal recy-
cling pool is much more considerable in L6 cells (61%) com-
pared with basal 3T3-L1 adipocytes (
10%). Although some
studies have reported higher basal rates of GLUT4 recycling in
adipocytes, even here this effect was smaller than we observe in
L6 cells in this study (25).
One of the key features of GLUT4 traffic in L6 myotubes
revealed by our kinetic study is the additivity observed in the
response to combined stimulationwith insulin andAMPK ago-
nists. This is apparent by the relative pool size of GLUT4 that
can be mobilized in response to these stimuli. The recycling
GLUT4 pool in the presence of the AMPK activators and insu-
lin is much greater than each agonist alone, indicating that
these agonists do not use a convergent signaling mechanism to
mobilize GLUT4. Additivity in glucose transport responses to
insulin and AMPK has been reported in a range ofmuscle types
(8, 11, 26–29), and our current studies suggest that part of this
effect could be associated with different processes that regulate
GLUT4 retention that are downstream of the insulin and
AMPK signaling systems. This could involve physically distinct
pools of GLUT4 as reported previously (30, 31), althoughmore
recent studies in cardiomyocytes have been unable to replicate
these findings (32). Alternatively, GLUT4 may be retained in a
similar location but by separate molecular mechanisms possi-
bly involving effectors such as the TBC proteins TBC1D1 and
AS160/TBC1D4, whichmay uniquely respond to either AMPK
or insulin, respectively (33).
In conclusion, studies on awide range of kinetic parameters for
GLUT4 traffic inmuscle are essential as stimulatory agonists have
multiple effects. Muscle cells appear to have built up a range of
mechanisms to increase cell surfaceGLUT4 levels so that they can
respond differently to hormones and metabolic changes. These
include diverse mechanisms for mobilization of intracellular
GLUT4 and for slowing GLUT4 internalization. It seems unlikely
that a single convergent step can account for the range of GLUT4
trafficking changes observed. This diversity in end point mecha-
nisms for increasing cell surface GLUT4 has implications in the
design of appropriate therapies for treatment of insulin resistance.
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